The Enzyme Experts
0
0
Resources
Company
Contact
X

Essential insights based on 3rd party publications:

Get the White Paper now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

Quantification Challenges of Chromatin — Associated Host Cell DNA:
An Underestimated Risk

  • Discover why host cell DNA quantities are often significantly underestimated.
  • Understand the limitation of conventional nucleases when degrading chromatin

Download the poster here
and get access to the
interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

The Largest Overlooked Cost Driver in Viral Vector Production

  • Up to half of produced vector is lost during Down Stream Processing(DSP)
  • The majority of manufacturing cost accumulates is DSP raw materials
  • Nuclease design decisions determine downstream economics

Download here and get access to the interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Investors News

R2D Ligase

Research Paper on ArcticZymes R2D Ligase Published in the Biotechnology Journal

Mar 27, 2024

Tromsø, Norway, March 27, 2024 - ArcticZymes Technologies ASA (OSE: AZT) Research Paper on ArcticZymes R2D Ligase™ is published in the Biotechnology Journal

Read More
Read More

ArcticZymes Technologies ASA Q4 2023 Results & Presentation

Feb 1, 2024

Tromsø, Norway, February 1st, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 28.4 million and an EBITDA of NOK 2.0 million for the fourth quarter of 2023.

Read More
Read More
New Product Launch - SAN HQ GMP

New Product Launch - SAN HQ GMP

Jan 30, 2024

Tromsø, Norway, January 30th, 2024 – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of Salt Active Nuclease High Quality GMP Grade (SAN HQ GMP).

Read More
Read More
launches T7 RNA Polymerase

ArcticZymes Technologies launches T7 RNA Polymerase

Dec 21, 2023

Tromsø, Norway, December 21, 2023 – ArcticZymes Technologies ASA (OSE: AZT) announced the launch of its new product, T7 RNA Polymerase. The T7 RNA Polymerase, specifically designed for molecular research and diagnostics, caters to the specialized needs of our customers in the Molecular Tools segment.

Read More
Read More